ASO Visual Abstract: Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial.
Ann Surg Oncol
; 30(8): 5081-5082, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37225831
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Ann Surg Oncol
Year:
2023
Document type:
Article